<SEC-DOCUMENT>0000950170-25-112314.txt : 20250829
<SEC-HEADER>0000950170-25-112314.hdr.sgml : 20250829
<ACCEPTANCE-DATETIME>20250829175547
ACCESSION NUMBER:		0000950170-25-112314
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250829
DATE AS OF CHANGE:		20250829

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Carisma Therapeutics Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				262025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87951
		FILM NUMBER:		251282295

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 401
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		2674916422

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 401
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sesen Bio, Inc.
		DATE OF NAME CHANGE:	20180516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HealthCap VII, L.P.
		CENTRAL INDEX KEY:			0001645161
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		18 AVENUE D'OUCHY
		CITY:			CH 1006 LAUSANNE
		STATE:			V8
		ZIP:			1000-1018
		BUSINESS PHONE:		41 21 614 3500

	MAIL ADDRESS:	
		STREET 1:		18 AVENUE D'OUCHY
		CITY:			CH 1006 LAUSANNE
		STATE:			V8
		ZIP:			1000-1018
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001068238-23-000046</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001645161</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>5</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.001 par value per share</securitiesClassTitle>
      <dateOfEvent>08/27/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001485003</issuerCIK>
        <issuerCUSIP>14216R101</issuerCUSIP>
        <issuerName>Carisma Therapeutics Inc.</issuerName>
        <address>
          <street1 xmlns="http://www.sec.gov/edgar/common">3675 Market Street</street1>
          <street2 xmlns="http://www.sec.gov/edgar/common">Suite 401</street2>
          <city xmlns="http://www.sec.gov/edgar/common">Philadelphia</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">PA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">19104</zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>HealthCap VII, L.P.</personName>
          <personPhoneNum>4121 614 3500</personPhoneNum>
          <personAddress>
            <street1 xmlns="http://www.sec.gov/edgar/common">Represented by HealthCap Investments SA</street1>
            <street2 xmlns="http://www.sec.gov/edgar/common">23 Avenue Villamont</street2>
            <city xmlns="http://www.sec.gov/edgar/common">Lausanne</city>
            <stateOrCountry xmlns="http://www.sec.gov/edgar/common">V8</stateOrCountry>
            <zipCode xmlns="http://www.sec.gov/edgar/common">CH-1005</zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Louis E. Rambo</personName>
          <personPhoneNum>(202) 416-6800</personPhoneNum>
          <personAddress>
            <street1 xmlns="http://www.sec.gov/edgar/common">Proskauer Rose LLP</street1>
            <street2 xmlns="http://www.sec.gov/edgar/common">1001 Pennsylvania Ave. NW, Suite 600 S</street2>
            <city xmlns="http://www.sec.gov/edgar/common">Washington</city>
            <stateOrCountry xmlns="http://www.sec.gov/edgar/common">DC</stateOrCountry>
            <zipCode xmlns="http://www.sec.gov/edgar/common">20004-2533</zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001645161</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>HealthCap VII, L.P.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>2014372</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>2014372</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
        <aggregateAmountOwned>2014372</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.8</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>HealthCap VII GP LLC</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>2014372</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>2014372</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
        <aggregateAmountOwned>2014372</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>4.8</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $0.001 par value per share</securityTitle>
        <issuerName>Carisma Therapeutics Inc.</issuerName>
        <issuerPrincipalAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">3675 Market Street</street1>
          <street2 xmlns="http://www.sec.gov/edgar/common">Suite 401</street2>
          <city xmlns="http://www.sec.gov/edgar/common">Philadelphia</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">PA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">19104</zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item5>
        <percentageOfClassSecurities>Items 5(a)-(c) and 5(e) of the Schedule 13D are hereby amended and supplemented as follows:

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentages set forth in row 13 are based on 41,788,096 shares of Common Stock outstanding as of August 5, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2024.</percentageOfClassSecurities>
        <numberOfShares>The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.</numberOfShares>
        <transactionDesc>The Reporting Persons have effected the following transactions related to the Common Stock since the filing of Amendment No. 4 to the Schedule 13D on August 21, 2025:

Sold 147,884 shares of Common Stock on August 22, 2025 at a price of $0.231 per share; sold 92,900 shares of Common Stock on August 25, 2025 at a price of $0.231 per share; sold 80,201 shares of Common Stock on August 26, 2025 at a price of $0.235 per share; sold 110,214 shares of Common Stock on August 27, 2025 at a price of $0.229 per share; sold 184,500 shares of Common Stock on August 28, 2025 at a price of $0.24667 per share; and sold 91,852 shares of Common Stock on August 29, 2025 at a price of $0.22037 per share.

Except as set forth above and as previously disclosed, the Reporting Persons have not effected any transactions related to the Common Stock during the past 60 days.</transactionDesc>
        <date5PercentOwnership>On August 29, 2025, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Common Stock.</date5PercentOwnership>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>HealthCap VII, L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Dag Richter</signature>
          <title>By: HealthCap VII GP LLC, its general partner; By: HealthCap Investments SA, its investment manager; By: Dag Richter, Director</title>
          <date>08/29/2025</date>
        </signatureDetails>
        <signatureDetails>
          <signature>/s/ Fabrice Bernhard</signature>
          <title>By: HealthCap VII GP LLC, its general partner; By: HealthCap Investments SA, its investment manager; By: Fabrice Bernhard, General Manager</title>
          <date>08/29/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>HealthCap VII GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Dag Richter</signature>
          <title>By: HealthCap Investments SA, its investment manager; By: Dag Richter, Director</title>
          <date>08/29/2025</date>
        </signatureDetails>
        <signatureDetails>
          <signature>/s/ Fabrice Bernhard</signature>
          <title>By: HealthCap Investments SA, its investment manager; By: Fabrice Bernhard, General Manager</title>
          <date>08/29/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
